An economic analysis suggests that targeting aging offers potentially larger economic gains than eradicating individual diseases. Slowing aging to increase life expectancy by 1 year is worth US$38 trillion, and by 10 years, US$367 trillion.

Prioritizing health of the world’s population would add 10 healthy years in midlife and $12 trillion to the global economy .